MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
Procaine Inhibits Proliferation and Migration and Promotes Cell Apoptosis in Osteosarcoma Cells by Upregulation of MicroRNA-133b	https://doi.org/10.3727/096504017X14878518291077	2017	Cell line 1 Master/Detail View	Cell line and drug 1 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Bufalin Inhibits Proliferation and Induces Apoptosis in Osteosarcoma Cells by Downregulating MicroRNA-221	https://doi.org/10.1155/2016/7319464	2016	Cell line 2 Master/Detail View	Cell line and drug 2 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Baicalein inhibits osteosarcoma cell proliferation and invasion through the miR-183/Ezrin pathway	https://doi.org/10.3892/mmr.2018.9036	2018	Cell line 2 Master/Detail View	Cell line and drug 2 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Decreased expression of tumor suppressive miR-874 and its clinical significance in human osteosarcoma	https://doi.org/10.4238/2015.December.23.19	2015	Cell line 6 Master/Detail View	Cell line and drug 2 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth	https://doi.org/10.1016/j.bcp.2015.10.015	2015	Cell line 2 Master/Detail View	Cell line and drug 2 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Green tea polyphenol EGCG suppresses osteosarcoma cell growth through upregulating miR-1	https://doi.org/10.1007/s13277-015-4187-3	2016	Cell line 2 Master/Detail View	Cell line and drug 2 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-33a Mediates the Anti-Tumor Effect of Lovastatin in Osteosarcoma by Targeting CYR61	https://doi.org/10.1159/000495396	2018	Cell line 2 Master/Detail View	Cell line and drug 2 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
p16(INK4A) inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-?1	https://doi.org/10.1002/mc.22299	2016	Cell line 1 Master/Detail View	Cell line and drug 1 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Matrix metallopeptidase 9 targeted by hsa-miR-494 promotes silybin-inhibited osteosarcoma	https://doi.org/10.1002/mc.22753	2018	Cell line 2 Master/Detail View	Cell line and drug 2 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Upregulation of miR-328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas	https://doi.org/10.18632/oncotarget.3088	2015	Cell line 0 Master/Detail View	Cell line and drug 5 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-1301/TRIAP1 Axis Participates in Epirubicin-Mediated Anti-Proliferation and Pro-Apoptosis in Osteosarcoma	https://doi.org/10.3349/ymj.2019.60.9.832	2019	Cell line 0 Master/Detail View	Cell line and drug 2 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Quercetin Enhances Cisplatin Sensitivity of Human Osteosarcoma Cells by Modulating microRNA-217-KRAS Axis	https://doi.org/10.14348/molcells.2015.0037	2015	Cell line 0 Master/Detail View	Cell line and drug 1 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
A combined gene expression and functional study reveals the crosstalk between N-Myc and differentiation-inducing microRNAs in neuroblastoma cells	https://doi.org/10.18632/oncotarget.12676	2016	Cell line 15 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas	https://doi.org/10.18632/oncotarget.7434	2016	Cell line 13 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
microRNA-558 facilitates the expression of hypoxia-inducible factor 2 alpha through binding to 5'-untranslated region in neuroblastoma	https://doi.org/10.18632/oncotarget.9813	2016	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
microRNA-558 facilitates the expression of hypoxia-inducible factor 2 alpha through binding to 5'-untranslated region in neuroblastoma	https://doi.org/https://doi.org/10.18632/oncotarget.9813	2016	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miRNA-558 promotes tumorigenesis and aggressiveness of neuroblastoma cells through activating the transcription of heparanase	https://doi.org/10.1093/hmg/ddv018	2015	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
MiR-192 directly binds and regulates Dicer1 expression in neuroblastoma	https://doi.org/10.1371/journal.pone.0078713	2013	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
MicroRNA-141 and its associated gene FUS modulate proliferation, migration and cisplatin chemosensitivity in neuroblastoma cell lines	https://doi.org/10.3892/or.2016.4640	2016	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells	https://doi.org/10.3892/or.2016.4676	2016	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View

Publications